Evaluation of treatment response using integrated 18F-labeled choline positron emission tomography/magnetic resonance imaging in adolescents with intracranial non-germinomatous germ cell tumours

被引:8
作者
Tsouana, Eva [1 ]
Stoneham, Sara [1 ]
Fersht, Naomi [2 ]
Kitchen, Neil [4 ]
Gaze, Mark [2 ]
Bomanji, Jamshed [3 ]
Fraioli, Francesco [3 ]
Hargrave, Darren [5 ]
Shankar, Ananth [1 ]
机构
[1] Univ Coll London Hosp NHS Fdn Trust, Dept Pediat & Adolescent Oncol, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Oncol, London, England
[3] Univ Coll London Hosp NHS Fdn Trust, Inst Nucl Med, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, Dept Neurosurg, London, England
[5] Great Ormond St Hosp Sick Children, Dept Pediat Oncol, London, England
关键词
18F-fluoroethyl-choline; choline; intracranial germ cell tumours; neuro-oncolgy; PET; positron emission tomography; BRAIN; THERAPY; PET;
D O I
10.1002/pbc.25538
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficacy of hybrid 18F-Fluroethyl-Choline (FEC) positron emission tomography (PET)/magnetic resonance imaging (MRI) was investigated as an imaging modality for diagnosis and assessment of treatment response and remission status in four patients with proven or suspected intracranial non-germinomatous germ cell tumours (NGGCT). In two patients faint or absent choline avidity correlated with negative histology, whereas in other two patients, persistent choline avidity in the residual mass was suggestive of presence of viable tumour, subsequently confirmed histologically. We conclude that FEC-PET/MRI may be an effective imaging tool in detecting viable residual tumour in patients with intracranial NGGCT post treatment. Pediatr Blood Cancer 2015;62:1661-1663. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:1661 / 1663
页数:3
相关论文
共 14 条
  • [1] SURGICAL-MANAGEMENT OF PINEAL REGION TUMORS
    BRUCE, JN
    STEIN, BM
    [J]. ACTA NEUROCHIRURGICA, 1995, 134 (3-4) : 130 - 135
  • [2] Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis
    Buchbender, Christian
    Heusner, Till A.
    Lauenstein, Thomas C.
    Bockisch, Andreas
    Antoch, Gerald
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 928 - 938
  • [3] Fraioli F, 2014, CLIN NUCL MED
  • [4] Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas
    Hara, T
    Kondo, T
    Hara, T
    Kosaka, N
    [J]. JOURNAL OF NEUROSURGERY, 2003, 99 (03) : 474 - 479
  • [5] Intracranial germ cell tumours. A review with special reference to endocrine manifestations
    Jorsal, Tina
    Rorth, Mikael
    [J]. ACTA ONCOLOGICA, 2012, 51 (01) : 3 - 9
  • [6] Solitary brain lesions enhancing at MR imaging: Evaluation with fluorine 18-fluorocholine PET
    Kwee, Sandi A.
    Ko, Jehoon P.
    Jiang, Caroline S.
    Watters, Michael R.
    Coel, Marc N.
    [J]. RADIOLOGY, 2007, 244 (02) : 557 - 565
  • [7] Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-Early experience
    Lam, Winnie Wing-Chuen
    Ng, David Chee-Eng
    Wong, Wai Yin
    Ong, Seng Chuan
    Yu, Sidney Wing-Kwong
    See, Siew Ju
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (02) : 156 - 161
  • [8] Primary intracranial germ cell tumors: A clinical analysis of 153 histologically verified cases
    Matsutani, M
    Sano, K
    Takakura, K
    Fujimaki, T
    Nakamura, O
    Funata, N
    Seto, T
    [J]. JOURNAL OF NEUROSURGERY, 1997, 86 (03) : 446 - 455
  • [9] Carbon 11-labeled methionine positron emission tomography for detection of residual viable tumor cells after adjuvant therapy in nongerminomatous malignant germ cell tumors in 2 cases including an autopsy case
    Nakamura, Hideo
    Makino, Kelshi
    Kuratsu, Jun-ichi
    [J]. SURGICAL NEUROLOGY, 2009, 71 (01): : 83 - 88
  • [10] Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging
    Ohtani, T
    Kurihara, H
    Ishiuchi, S
    Saito, N
    Oriuchi, N
    Inoue, T
    Sasaki, T
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (11) : 1664 - 1670